drugset / Trial / NCT02757521

Nitrous TRD Bipolar Depression

NCT02757521

RandomizedParallel-groupDouble-blindTreatment

Summary

Investigators will study approximately 64 patients with Treatment-Resistant Bipolar Depressive Disorder, defined as a failure of at least 1 antidepressants in the current depressive episode and 2 lifetime medication failures. The study will last approximately 6 to 8 weeks, involving randomization into one of two treatment groups receiving 3 one hour long inhalation treatments over a week.

Timeline

Start
2016-03-25
Primary completion
2016-12-06
Completion
2016-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified Inhaled

Indications